Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study
- Status
- COMPLETED
- Phase
- PHASE2
Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment
- Status
- UNKNOWN
- Phase
- PHASE4
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy for Advanced Liver Cancer
- Status
- SUSPENDED
- Phase
- PHASE2/PHASE3
TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE3
Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML
- Status
- COMPLETED
- Phase
- N/A
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE3
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone
- Status
- COMPLETED
- Phase
- PHASE2
Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT
- Status
- TERMINATED
- Phase
- PHASE3
Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC
- Status
- WITHDRAWN
- Phase
- PHASE3
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
- Status
- UNKNOWN
- Phase
- PHASE3